Advertisement
Advertisement

INSM

INSM logo

Insmed, Inc.

174.84
USD
Sponsored
+0.80
+0.46%
Jan 02, 11:03 UTC -5
Open

INSM Earnings Reports

Positive Surprise Ratio

INSM beat 15 of 40 last estimates.

38%

Next Report

Date of Next Report
Feb 18, 2026
Estimate for Q4 25 (Revenue/ EPS)
$174.83M
/
-$1.33
Implied change from Q3 25 (Revenue/ EPS)
+22.83%
/
-24.00%
Implied change from Q4 24 (Revenue/ EPS)
+67.40%
/
+0.76%

Insmed, Inc. earnings per share and revenue

On Oct 30, 2025, INSM reported earnings of -1.75 USD per share (EPS) for Q3 25, missing the estimate of -1.36 USD, resulting in a -28.09% surprise. Revenue reached 142.34 million, compared to an expected 117.92 million, with a 20.71% difference. The market reacted with a +16.33% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 19 analysts forecast an EPS of -1.33 USD, with revenue projected to reach 174.83 million USD, implying an decrease of -24.00% EPS, and increase of 22.83% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
enGene Holdings Inc. Common Stock
Report Date
Dec 22, 2025 For Q4 25
Estimate
-$0.57
Actual
-$0.73
Surprise
-25.95%
logo
Outlook Therapeutics, Inc. Common Stock
Report Date
Dec 19, 2025 For Q4 25
Estimate
-$0.25
Actual
-$0.19
Surprise
+26.47%
logo
Citius Oncology, Inc. Common Stock
Report Date
Dec 23, 2025 For Q4 25
Estimate
-$0.12
Actual
-$0.06
Surprise
+50.98%
FAQ
For Q3 2025, Insmed, Inc. reported EPS of -$1.75, missing estimates by -28.09%, and revenue of $142.34M, 20.71% above expectations.
The stock price moved up 16.33%, changed from $166.95 before the earnings release to $194.22 the day after.
The next earning report is scheduled for Feb 18, 2026.
Based on 19 analysts, Insmed, Inc. is expected to report EPS of -$1.33 and revenue of $174.83M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement